ACADIA Pharmaceuticals Competitors and Similar CompaniesClear all
ACADIA Pharmaceuticals's competitors and similar companies include Neuraly and Alector.
 ACADIA Pharmaceuticals ACADIA Pharmaceuticals (formerly Receptor Technologies) is a biopharmaceutical company developing medicines that address medical needs in related central nervous system (CNS) disorders. |  Neuraly Neuraly is a clinical-stage biotechnology company that specializes in the development of drugs for neurodegenerative diseases. |  Alector Alector is a biotechnology company that develops therapies for the treatment of neurodegenerative diseases. | |
Founding Date | Founding Date 1993 | Founding Date 2016 | Founding Date 2013 |
Type | Type Public | Type Subsidiary | Type Public |
Tags | |||
Locations | Locations San Diego, US HQ Princeton, US | Locations Gaithersburg, US HQ | Locations San Francisco, US HQ |
Employees | Employees 513 | Employees 186% increase | Employees 2382% decrease |
Valuation ($) | Valuation ($) 2.4 b | Valuation ($) N/A | Valuation ($) 495.3 m |
Financial | |||
Revenue (est.) | Revenue (est.) $1.1b (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $21m (FY, 2025) |
Net income | Net income $391m (FY, 2025) | Net income N/A | Net income ($142.9m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 770.8m | Total funding raised $ 36m | Total funding raised $ 194.5m |
For sources of this data, please see the company profile
View Company Profiles
Neuraly
HQ
Gaithersburg, US
Neuraly is a clinical-stage biotechnology company that specializes in the development of drugs for neurodegenerative diseases.
View companyAlector
HQ
San Francisco, US
Employees
238↓ 2% decrease
Alector is a biotechnology company that develops therapies for the treatment of neurodegenerative diseases.
View company